Figure 1.
Experimental layout and timepoints.
MSCs were harvested from the tuber ischiadicum and chondrocytes from fetlock joints, and both cells were encapsuled in alginate beads. While the MSCs were differentiated chondrogenically for three weeks (day -21 to day 0), the chondrocytes were kept in serum medium for two weeks (day -14 to day 0). The beads were then submitted to hormonal treatment for five weeks (day 0 to day 35) with weekly samples for analysis.
Figure 2.
Production of DNA, GAG and HYP and collagen mRNA expression during chondrogenic MSC differentiation.
The upper graph A shows the changes in total DNA content per bead (or per pellet, respectively) during the differentiation and the increase of proteoglycans and hydroxyproline as a sign of extra cellular matrix production. Both pellet cultures and alginate bead cultures show an increase in GAG, but only in alginate beads, also collagen is produced and retained. Shown is the mean of three samples per animal (n=6) +/- standard error of the mean (SEM).
The lower graph B shows the fold-increase (mean +/- SD) of collagen mRNA, compared to undifferentiated MSCs kept in monolayer in expansion medium for 3 weeks. The bars compare alginate beads with and without TGF-β1 vs. pellet cultures with and without TGF-β1. Alginate beads with TGF-β1 show the highest increase in Col II mRNA expression, indicating that the culture system is well suited for chondrogenic differentiation of the MSCs.
Figure 3.
Shown is the relative DNA content in articular chondrocytes (A), with day 0 being the reference and indicating the beginning of the hormonal treatment phase and day -14 showing the DNA content right after encapsulation. DNA content ranged from 96% to 121% of day 0 amounts, with no significant differences between treatment groups or over time. The second graph (B) shows the DNA content in the MSCs before and during differentiation (Day -21 to Day 0) and under the influence of T3 and Dex. The significant cell proliferation that occurred during the chondrogenic differentiation (Day 0 vs. Day 21, p<0.01) did not continue in the serum free treatment medium, indicating its dependence on TGF-β1.
Figure 4.
mRNA expression of Col I and Col II.
Displayed is the relative change in Col type I and II mRNA in chondrocytes (A and B) under hormonal treatment vs. control, and in the MSCs (C and D, respectively). The expression was calibrated to 18S and normalized to control at day 0. Dex decreased Col I mRNA expression in both cell types significantly, but in greater scale in the chondrocytes (Dex vs. control with P < 0.001 after 21 days of culture). Col II mRNA was not significantly regulated by Dex, but decreased through T3 in MSCs and increased in chondrocytes.
Figure 5.
Markers of hypertrophy in chondrocyte and MSC culture.
Shown is the relative change in Col type X mRNA in chondrocytes (A) and MSCs (B) and the total level of ALP activity (C and D, respectively). Both markers demonstrate that for articular chondrocytes, T3 can induce terminal differentiation in the cells, while chondrogenically differentiated MSCs show a similar response but to dexamethasone instead.
Figure 6.
Stained cryosections of a pellet culture and an alginate bead.
Alcian blue stain of 8 µm Cryosections of an alginate bead culture (A) and an MSC pellet culture (B) after 21 days of chondrogenic differentiation. Proteoglycans show in blue. The gaps in the alginate bead section are artifacts from the cutting. The scale bar represents 500 µm.
Figure 7.
GAG content over time in the treatment groups.
Shown is the relative GAG per DNA content of chondrocytes (A) and MSCs (B), with day 0 being the reference and indicating the beginning of the hormonal treatment. Absolute amounts of GAG reached more than 60 µg GAG/µg DNA or more than 80 µg of GAG per bead in the Dex group. After changing to serum-free hormonal treatment medium, Dex enhanced the GAG production significantly more than T3 or control medium (seen from day 21 on, with P < 0.001) and showed a general increase over time. A further increase with T3 after preculture serum showed only at day 28 (P < 0.01 vs. day 0), the control group had no significant increase in GAG/DNA after change to serum free medium. The MSCs behaved similar in their response to Dex, with significant increase in GAG production after two weeks (P < 0.01 at day 14 and 21 vs. day 0, and P < 0.0001 afterwards), but T3 seemed to rather decrease GAG production.
Figure 8.
Proteoglycan visualization in alcian blue staining of alginate beads.
Freshly prepared beads (A) only have slight background staining of alcian blue, almost all proteoglycans are removed from the cells during the digestion process. In the overview after serum preculture and five weeks of culture (B), the cells impose as round, singular cells with surrounding deep-blue pericellular matrix and further removed matrix in the gel. No differences can be visualized in the GAG content between T3-treated (C) and Dex-treated (D) chondrocytes.
Figure 9.
Hydroxyproline production in chondrocytes.
Total amount of HYP was quantified and calibrated to the total amount of DNA, to equalize for production merely due to increased or decreased cell number. Shown are the results of the quantification in the articular chondrocytes (A) and the MSCs (B) before and during hormonal treatment, as mean +/- SD.
Figure 10.
Alizarin red background stain in alginate beads.
Freshly prepared beads, stained with AR with (A) representing a bead seeded with chondrocytes and (B) a bead with MSCs. Both show considerable high but very similar background staining, due to the use of CaCl2 for crosslinking. The calcium ions remain crosslinked in the alginate throughout the culture period.
Figure 11.
Calcium incorporation in alginate beads with MSCs.
For MSC beads, we found an increase in the uptake of AR from day -21 (A) before differentiation and day 0 (B). The Dex-treated beads then showed a much more intense staining, and at higher magnification, the Dex-treated cells (D) showed a pericellular matrix and dark red calcium depositions around the cells, which was not seen at this intensity in the other, T3-treated samples (C).
Figure 12.
Calcium incorporation in alginate beads with chondrocytes.
Between day -14 (A) and day 0 (B) no major increase was seen in AR uptake. Chondrocyte seeded beads treated with T3 (C) showed then a more heterogeneous stain of AR after induction, as compared to the dex-treated group (D).